These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12950423)

  • 1. Effects of asimadoline, a kappa-opioid agonist, on satiation and postprandial symptoms in health.
    Delgado-Aros S; Chial HJ; Cremonini F; Ferber I; McKinzie S; Burton DD; Camilleri M
    Aliment Pharmacol Ther; 2003 Sep; 18(5):507-14. PubMed ID: 12950423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia.
    Talley NJ; Choung RS; Camilleri M; Dierkhising RA; Zinsmeister AR
    Aliment Pharmacol Ther; 2008 Jun; 27(11):1122-31. PubMed ID: 18331462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans.
    Delgado-Aros S; Chial HJ; Camilleri M; Szarka LA; Weber FT; Jacob J; Ferber I; McKinzie S; Burton DD; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G558-66. PubMed ID: 12631557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation.
    Camilleri M
    Neurogastroenterol Motil; 2008 Sep; 20(9):971-9. PubMed ID: 18715494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent influences of body mass and gastric volumes on satiation in humans.
    Delgado-Aros S; Cremonini F; Castillo JE; Chial HJ; Burton DD; Ferber I; Camilleri M
    Gastroenterology; 2004 Feb; 126(2):432-40. PubMed ID: 14762780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study.
    Vella A; Bock G; Giesler PD; Burton DB; Serra DB; Saylan ML; Deacon CF; Foley JE; Rizza RA; Camilleri M
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):737-44. PubMed ID: 18331607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of somatostatin analog on postprandial satiation in obesity.
    Cremonini F; Camilleri M; Gonenne J; Stephens D; Oenning L; Baxter K; Foxx-Orenstein A; Burton D
    Obes Res; 2005 Sep; 13(9):1572-9. PubMed ID: 16222060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.
    Binder W; Walker JS
    Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of asimadoline, a new kappa-opioid receptor agonist, on tubular water absorption and vasopressin secretion in man.
    Kramer HJ; Uhl W; Ladstetter B; Bäcker A
    Br J Clin Pharmacol; 2000 Sep; 50(3):227-35. PubMed ID: 10971307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant.
    Jacob D; Busciglio I; Burton D; Halawi H; Oduyebo I; Rhoten D; Ryks M; Harmsen WS; Camilleri M
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G505-G510. PubMed ID: 28814387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers.
    Castillo EJ; Delgado-Aros S; Camilleri M; Burton D; Stephens D; O'Connor-Semmes R; Walker A; Shachoy-Clark A; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G363-9. PubMed ID: 15246968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of gastric emptying or accommodation with satiation, satiety, and postprandial symptoms in health.
    Halawi H; Camilleri M; Acosta A; Vazquez-Roque M; Oduyebo I; Burton D; Busciglio I; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G442-G447. PubMed ID: 28774870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial.
    Bouras EP; Talley NJ; Camilleri M; Burton DD; Heckman MG; Crook JE; Richelson E
    Am J Gastroenterol; 2008 Aug; 103(8):2043-50. PubMed ID: 18803000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study.
    Esfandyari T; Camilleri M; Ferber I; Burton D; Baxter K; Zinsmeister AR
    Neurogastroenterol Motil; 2006 Sep; 18(9):831-8. PubMed ID: 16918762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological modulation of human gastric volumes demonstrated noninvasively using SPECT imaging.
    Liau SS; Camilleri M; Kim DY; Stephens D; Burton DD; O'Connor MK
    Neurogastroenterol Motil; 2001 Dec; 13(6):533-42. PubMed ID: 11903914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study.
    Delgado-Aros S; Camilleri M; Castillo EJ; Cremonini F; Stephens D; Ferber I; Baxter K; Burton D; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2005 Oct; 3(10):997-1006. PubMed ID: 16234046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ghrelin receptor agonist, relamorelin, on gastric motor functions and satiation in healthy volunteers.
    Nelson AD; Camilleri M; Acosta A; Busciglio I; Linker Nord S; Boldingh A; Rhoten D; Ryks M; Burton D
    Neurogastroenterol Motil; 2016 Nov; 28(11):1705-1713. PubMed ID: 27283792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome.
    Delvaux M; Beck A; Jacob J; Bouzamondo H; Weber FT; Frexinos J
    Aliment Pharmacol Ther; 2004 Jul; 20(2):237-46. PubMed ID: 15233705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial.
    Halawi H; Khemani D; Eckert D; O'Neill J; Kadouh H; Grothe K; Clark MM; Burton DD; Vella A; Acosta A; Zinsmeister AR; Camilleri M
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):890-899. PubMed ID: 28958851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans.
    Delgado-Aros S; Kim DY; Burton DD; Thomforde GM; Stephens D; Brinkmann BH; Vella A; Camilleri M
    Am J Physiol Gastrointest Liver Physiol; 2002 Mar; 282(3):G424-31. PubMed ID: 11841992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.